Summary
Routine laboratory investigations performed on the serum of an 8-year-old girl examined because of a moderate degree of iron-deficiency anemia showed a markedly reduced C3 level. More detailed complement studies revealed a selective C3 deficiency, as indicated by the almost undetectable C3 concentration tested by both hemolytic and immunochemical assays and by the normal or slightly reduced levels of all the other complement components. The hemolytic activity of the serum was restored by the addition of partially purified C3 component. The isolated C3 deficiency could be attributed to the presence of a C3-cleaving activity in the serum of the propositus. This activity was identified as C3 nephritic factor (C3NeF) since it was heat-stable, was absorbed by Cowan I strain ofStaphylococcus aureus and was eluted in the IgG fraction after DEAE-chromatography of the serum. The levels of H and I factors of the alternative pathway in the serum of the propositus and of C3 in the serum samples of her parents and two siblings were found to be within the normal range. The previous clinical history of the girl and the follow-up for a period of approximately 5 years showed that she was apparently healthy and did not reveal clinical and/or laboratory evidence of glomerulonephritis, lipodystrophy or repeated bacterial infections usually associated with the presence of C3NeF in the serum.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alper C. A., Bloch K. J., Rosen F. S.: Increased susceptibility to infection in a patient with type II essential hypercatabolism of C3 — New Engl. J. Med.288, 601, 1973.
Charlesworth J. A., Williams D. G., Sherington E., Lachmann P. J., Peters D. K.: Metabolic studies of the third component of complement and the glycine-rich β-glycoprotein in patients with hypocomplementemia — J. clin. Invest.53, 1578, 1974.
Daha M. R., Fearon D. T., Austen K. F.: C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase — J. Immunol.116, 1, 1976.
Davis A. E., Ziegler J. B., Gelfand E. W., Rosen F. S., Alper C. A.: Heterogeneity of nephritic factor and its identification as an immunoglobulin — Proc. nat. Acad. Sci. (Wash.)74, 3980, 1977.
Edwards K. M., Alford R., Gewurz H., Mold C.: Recurrent bacterial infections associated with C3 nephritic factor and hypocomplementemia — New Engl. J. Med.308, 1138, 1983.
Gewurz A. T., Imherr S. M., Strauss S., Gewurz H., Mold C.: C3 nephritic factor and hypocomplementaemia in a clinically healthy individual — Clin. exp. Immunol.54, 253, 1983.
Ipp M. M., Minta J. O., Gelfand E. W.: Disorders of the complement system in lipodystrophy — Clin. Immunol. Immunopathol.7, 281, 1977.
Jonsson S., Kronvall G.: The use of protein A-containingStaphylococcus aureus as a solid-phase anti-IgG reagent in radioimmunoassays as exemplified in the quantitation of α-fetoprotein in normal adult serum — Europ. J. Immunol.4, 29, 1974.
Karstorp A.: C3 activator and hypocomplementaemia in a healthy woman — Brit. med. J.i, 501, 1976.
Lachmann P. J., Hobart M. J.: Complement technology. In:Weir D. M. (Ed.): Handbook of experimental immunology. Blackwell Sci. Publ., Oxford, 1978; chapt. 5A.
Ochs H. D.,HeathS. R.,Jackson C. G.,Osofsky S. G.,Ralson A. R.,Wedgewood R. J.: Complement and the antibody response — Clin. Res.27, 332A, 1979.
Peters D. K., Martin A., Weinstein A., Barratt T. M., Cameron J. S., Ogg C. S., Lachmann P. J.: Complement studies in membranoproliferative glomerulonephritis — Clin. exp. Immunol.11, 311, 1972.
Peters D. K., Williams D. G., Charlesworth J. A., Boulton-Jones J. M., Sissons J. G. P., Evans D. J., Kourilsky O., Morel-Maroger L.: Mesangiocapillary nephritis, partial lipodystrophy, and hypocomplementaemia — Lancetii, 535, 1973.
Schaak T. M., Persellin R. H.: Chemotaxis under agarose: dependence upon polymorphonuclear leukocyte density — J. immunol. Meth.47, 359, 1981.
Scott D. M., Amos N., Sissons J. G. P., Lachmann P. J., Peters D. K.: The immunoglobulin nature of nephritic factor (NeF) — Clin. exp. Immunol.32, 12, 1978.
Sissons J. G. P., West R. J., Fallows J., Williams D. G., Boucher B. J., Amos N., Peters D. K.: The complement abnormalities of lipodystrophy — New Engl. J. Med.294, 461, 1976.
Spitzer R. E., Vallota E. H., Forristal J., Sudora E., Stitzel A., Davis N. C., West C. D.: Serum C’3 lytic system in patients with glomerulonephritis — Science164, 436, 1969.
Tedesco F., Bardare M., Giovanetti A. M., Sirchia G.: A familial dysfunction of the eighth component of complement (C8) — Clin. Immunol. Immunopathol.16, 180, 1980.
Tedesco F., Densen P., Villa M. A., Petersen B. H., Sirchia G.: Two types of dysfunctional eighth component of complement (C8) molecules in C8 deficiency in man — J. clin. Invest.71, 183, 1983.
Tedesco F., Rottini G. D., Patriarca P.: Modulating effect of the late-acting components of the complement system on the bactericidal activity of human polymorphonuclear leukocytes onE. coli 0111:B4 — J. Immunol.127, 1910, 1981.
Thompson R. A.: C3-inactivating factor in the serum of a patient with chronic hypocomple-mentaemic proliferative glomerulonephritis — Immunology22, 147, 1972.
Thompson R. A., White R. H. R.: Partial lipodystrophy and hypocomplementaemic nephritis — Lancetii, 679, 1973.
Thompson R. A., Yap P. L., Brettle R. B., Dunmow R. E., Chapel H.: Meningococcal meningitis associated with persistent hypocomplementaemia due to circulating C3 nephritic factor — Clin. exp. Immunol.52, 153, 1983.
Vallota E. H.,Forristal J.,Spitzer R. E.,Davis N. C.,West C. D.: Characteristics of a non-complement-dependent C3-reactive complex formed from factors in nephritic and normal serum — J. exp. Med.131, 1306a, 1970.
Williams D. G., Bartlett A., Duffus P.: Identification of nephritic factor as an immunoglobulin — Clin. exp. Immunol.33, 425, 1978.
Author information
Authors and Affiliations
Additional information
This work was supported by a grant from theConsiglio Nazionale delle Ricerche (CNR), Roma, Italy,Progetto Finalizzato ‘Ingegneria Genetica’, Sottoprogetto ‘Basi Molecolari delle Malattie Ereditarie’.
Nomenclature of complement components conforms to that agreed upon by the world Health Organization (Bull. wld Hlth Org.39, 935, 1968 and Bull Wld Hlth Org.59, 489, 1981).
Rights and permissions
About this article
Cite this article
Tedesco, F., Tovo, P.A., Tamaro, G. et al. Selective C3 deficiency due to C3 nephritic factor in an apparently healthy girl. La Ricerca in Clin. Lab. 15, 323–329 (1985). https://doi.org/10.1007/BF03029146
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF03029146